KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calumet (CLMT) Gains from Sales and Divestitures (2022 - 2025)

Calumet (CLMT) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $898911.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures rose 338.33% to $898911.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $898911.0, a 338.33% increase, with the full-year FY2025 number at $898911.0, up 338.33% from a year prior.
  • Gains from Sales and Divestitures was $898911.0 for Q4 2025 at Calumet, up from $205074.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.7 million in Q4 2022 to a low of $205074.0 in Q4 2024.
  • A 4-year average of $988827.5 and a median of $1.0 million in 2023 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: crashed 82.08% in 2024, then soared 338.33% in 2025.
  • Calumet's Gains from Sales and Divestitures stood at $1.7 million in 2022, then crashed by 32.94% to $1.1 million in 2023, then plummeted by 82.08% to $205074.0 in 2024, then skyrocketed by 338.33% to $898911.0 in 2025.
  • Per Business Quant, the three most recent readings for CLMT's Gains from Sales and Divestitures are $898911.0 (Q4 2025), $205074.0 (Q4 2024), and $1.1 million (Q4 2023).